Published in J Am Acad Dermatol on December 01, 2000
Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages. Autoimmunity (2008) 0.93
Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris. J Am Acad Dermatol (2003) 0.80
Seeking approval: present and future therapies for pemphigus vulgaris. Curr Opin Investig Drugs (2008) 0.77
Therapy of autoimmune bullous diseases. Ther Clin Risk Manag (2007) 0.77
Pulse cyclophosphamide therapy in refractory warm autoimmune hemolytic anemia: a new perspective. Indian J Hematol Blood Transfus (2013) 0.76
Structure of the replicative form of bacteriphage phi X174. VI. Studies on alkali-denatured double-stranded phi X DNA. J Mol Biol (1968) 11.10
Structure of the replicative form of bacteriophage phi-X-174. VII. Renaturation of denatured double-stranded phi-X DNA. J Mol Biol (1969) 10.46
Studies on mustard gas (betabeta'-dichlorodiethyl sulphide) and some related compounds: 5. The fate of injected mustard gas (containing radioactive sulphur) in the animal body. Biochem J (1946) 4.41
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (1989) 3.27
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology (2004) 2.50
Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology (1992) 2.41
A quantitative assay for DNA-DNA hybrids using membrane filters. Biochem Biophys Res Commun (1966) 2.32
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med (1980) 2.21
The mechanism of damage to the bone marrow in systemic poisoning with mustard gas. Biochem J (1947) 2.16
The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci (1979) 2.12
Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology (2008) 2.04
Different inherited levels of DNA repair replication in xeroderma pigmentosum cell strains after exposure to ultraviolet irradiation. Mutat Res (1970) 2.03
Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis (1993) 1.92
Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care (1994) 1.74
Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J Neurochem (1999) 1.73
The treatment of scabies with ivermectin. N Engl J Med (1995) 1.60
Adsorption of monovalent and divalent cations by phospholipid membranes. The monomer-dimer problem. Biophys J (1981) 1.55
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology (2008) 1.53
Stage- and tissue-specific expression of the neu oncogene in rat development. Proc Natl Acad Sci U S A (1987) 1.52
The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology (2009) 1.49
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology (2003) 1.46
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
Confirmation by magnetic resonance imaging of optic nerve injury after retrobulbar anesthesia. Arch Ophthalmol (1996) 1.41
Multiple sclerosis: the importance of early recognition and treatment. Cleve Clin J Med (2001) 1.40
Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein. Oncogene (1989) 1.34
Contractile effects of a calcium ionophore. Nature (1973) 1.31
Sarcoidosis. An updated review. J Am Acad Dermatol (1984) 1.30
Formation of complexes between DNA isolated from tobacco crown gall tumours and RNA complementary to Agrobacterium tumefaciens DNA. Biochim Biophys Acta (1967) 1.30
Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res (1990) 1.26
Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24
An improved fit to Website osmotic pressure data. Biophys J (1997) 1.20
Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis. Cell Immunol (1987) 1.20
Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. J Comp Neurol (1993) 1.20
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
Left-sided heart failure presenting as hepatitis. Gastroenterology (1978) 1.19
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis. J Neurol (2014) 1.18
The face, beauty, and symmetry: perceiving asymmetry in beautiful faces. Int J Neurosci (2005) 1.17
Assessing disability progression with the Multiple Sclerosis Functional Composite. Mult Scler (2009) 1.15
Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Mult Scler (2007) 1.14
Interaction of charged lipid vesicles with planar bilayer lipid membranes: detection by antibiotic membrane probes. J Supramol Struct (1976) 1.13
Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells. J Clin Invest (1992) 1.12
Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation. Mol Pharm (2006) 1.11
The mast cell in health and disease. J Am Acad Dermatol (1990) 1.10
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Bilateral orbital varices associated with habitual bending. Arch Ophthalmol (1995) 1.08
Management of multiple sclerosis. N Engl J Med (1997) 1.08
Structure of the replicative form of bacteriophage phi-X-174. Physico-chemical studies. Biochim Biophys Acta (1966) 1.07
Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products. Neurosci Lett (2000) 1.06
Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. Kidney Int (1998) 1.06
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy. Mult Scler (2013) 1.05
Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology (1995) 1.05
Treatment for sexually abused children and adolescents. Am Psychol (2000) 1.04
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Secondary penile malignancies: the spectrum of presentation. J Surg Oncol (1992) 1.03
Development of biologically active peptides based on antibody structure. Proc Natl Acad Sci U S A (1989) 1.03
Identification of the A-band localization domain of myosin binding proteins C and H (MyBP-C, MyBP-H) in skeletal muscle. J Cell Sci (1999) 1.03
Sedimentation-viscosity studies of high molecular weight DNA. J Mol Biol (1965) 1.02
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects. Mult Scler (2002) 1.01
Treatment of chickenpox pneumonia with adenine arabinoside. Lancet (1979) 1.00
Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface. Arch Dermatol (1998) 0.99
Sterically stabilized liposomes: physical and biological properties. J Drug Target (1994) 0.99
Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol (1995) 0.98
Serum angiotensin-converting enzyme in multiple sclerosis. Arch Neurol (1997) 0.98
Distribution of neu (c-erbB-2) protein in human skin. J Invest Dermatol (1989) 0.96
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta. Mult Scler (2005) 0.94
Performance comparison of nylon and an absorbable suture material (Polyglactin 910) in the closure of punch biopsy sites. Dermatol Surg (2000) 0.94
The changing status of inpatient dermatology at American academic dermatology programs. J Am Acad Dermatol (1999) 0.94
Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exp Nephrol (1996) 0.93
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses. J Am Acad Dermatol (1991) 0.92
Pityriasis rubra pilaris and HIV infection. J Am Acad Dermatol (1991) 0.92
Characterization of multiple sclerosis plaques with T1-weighted MR and quantitative magnetization transfer. AJNR Am J Neuroradiol (1995) 0.92
Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells. Am J Physiol (1999) 0.91
Stoichiometric and electrostatic characterization of calcium binding to native and lipid-substituted adenosinetriphosphatase of sarcoplasmic reticulum. Biochim Biophys Acta (1985) 0.90
Tubular alterations produced by osmotic diuresis with mannitol. Ann Intern Med (1965) 0.90
Cutaneous large-cell lymphoma histologically resembling sarcoidosis. J Am Acad Dermatol (1993) 0.90
Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia. Lancet (1991) 0.90
Who should care for hospitalized patients with severe skin disease? Arch Dermatol (1998) 0.90
Eosinophilic fasciitis responsive to treatment with pulsed steroids and cyclosporine. Int J Dermatol (1999) 0.89
Two functional states of sarcoplasmic reticulum ATPase. Biochemistry (1976) 0.89
Reiter syndrome. Int J Dermatol (1991) 0.89
Widespread primary cutaneous infection with Mycobacterium fortuitum. Int J Dermatol (1993) 0.89
Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment. Neurology (2000) 0.88
Post-traumatic torticollis. Neurology (1989) 0.88
Recalcitrant giant molluscum contagiosum in a patient with AIDS. J Am Acad Dermatol (1996) 0.88
Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. Neurology (2012) 0.87
Mast cell participation during the elicitation of murine allergic contact hypersensitivity. J Invest Dermatol (1987) 0.87
The transcription in vitro of various forms of phiX174 DNA. Biochim Biophys Acta (1969) 0.86
Subarachnoid hemorrhage precipitated by cocaine snorting. Arch Neurol (1984) 0.86
Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma. Am J Pathol (1998) 0.86
Inpatient dermatology. A prescription for survival. Dermatol Clin (2001) 0.86
Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med (1994) 0.85
Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. Metabolism (1999) 0.84